Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Stomach (Gastric) Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Overview

Note: Separate PDQ summaries on Stomach (Gastric) Cancer Prevention, Gastric Cancer Treatment, and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Benefits

Recommended Related to Cancer

Ewing Sarcoma: Metastatic Tumors

Metastases at diagnosis are detected in approximately 25% of patients.[1] The prognosis of patients with metastatic disease is poor. Current therapies for patients who present with metastatic disease achieve 6-year event-free survival (EFS) of approximately 28% and overall survival (OS) of approximately 30%.[2,3] For patients with lung/pleural metastases only, 6-year EFS is approximately 40% when utilizing bilateral lung irradiation.[2,4] In contrast, patients with bone/bone marrow metastases have...

Read the Ewing Sarcoma: Metastatic Tumors article > >

Based on fair evidence, screening would not result in a decrease in mortality from gastric cancer in areas with relatively low incidence of the disease, such as the United States.

Magnitude of Effect: Fair evidence for no reduction in mortality.

  • Study Design: Evidence obtained from case-control and cohort studies, primarily from high-risk areas such as Eastern Asia.
  • Internal Validity: Fair.
  • Consistency: Poor in prospective studies.[1]
  • External Validity: Poor. Studies on populations in high-risk areas may not be applicable to low-risk areas such as the United States.

Harms

Based on solid evidence, screening would result in uncommon but serious side effects associated with endoscopy, which may include perforation, cardiopulmonary events, aspiration pneumonia, and bleeding requiring hospitalization.

False-positive tests are also common in association with serum pepsinogen or gastric photofluorography.

Magnitude of Effect: Good evidence for rare but serious harms.

Description of the Evidence

  • Study Design: Evidence obtained from screening programs and from case series.
  • Internal Validity: Fair.
  • Consistency: Inadequate evidence.
  • External Validity: Poor.

References:

  1. Leung WK, Wu MS, Kakugawa Y, et al.: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9 (3): 279-87, 2008.
1

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Colorectal cancer cells
A common one in both men and women.
Lung cancer xray
See it in pictures, plus read the facts.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article